Valganciclovir Clinical Trials
7 recruitingDrug
Phase 24Phase 32Phase 11Phase 41
Showing 1–7 of 7 trials
Recruiting
Phase 2
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
CMV ViremiaBrain Cancer Metastatic
The Methodist Hospital Research Institute28 enrolled1 locationNCT07383649
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Lactating Women on Select DOIBreastfed Infants of Mothers on Select DOI
Duke University1,600 enrolled22 locationsNCT03511118
Recruiting
Phase 3
Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections
Assistance Publique - Hôpitaux de Paris80 enrolled5 locationsNCT06334497
Recruiting
Phase 4
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients
Kidney Transplant
First Affiliated Hospital Xi'an Jiaotong University290 enrolled1 locationNCT07266467
Recruiting
Phase 2Phase 3
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Heart Transplant InfectionCMV ViremiaHeart Transplant Failure and Rejection
Columbia University150 enrolled2 locationsNCT07079735
Recruiting
Phase 2
CMV Immunity Monitoring in Lung Transplant Recipients
Lung Transplant; Complications
NYU Langone Health50 enrolled1 locationNCT05708755
Recruiting
Phase 1Phase 2
ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION
Major Depressive Disorder
Laureate Institute for Brain Research, Inc.24 enrolled1 locationNCT04724447